This 5-year project falls under the European Union’s Horizon 2020 FET Open Program to fund projects on new ideas for radically new future technologies. This can involve a wide range of new technological possibilities inspired by cutting-edge science. The project was coordinated by Professor Frans van de Vosse of the Eindhoven University of Technology. The project aims to develop an artificial womb to increase the chances of survival for extremely premature born babies (born between 24-28 weeks). For these babies, the chances of survival increases with each day in the artificial womb, which serves as a replacement for an incubator.

The PLS consortium includes 5 partners from across Europe: Germany (UK RWTH Aachen University), Italy (Politecnico di Milano) and The Netherlands (TU/e, LifeTec Group, and Nemo Healthcare). They will combine their research expertise in the fields of cardiology, gynecology, biology, physics, as well as computer and simulation modelling to develop the components necessary for the artificial womb to provide perinatal life support. By the end of the project, the PLS consortium aims to establish technologies that will contribute to the first ex vivo fetal maturation system for clinical use.

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 863087.

For more (product) information, please contact:
René Kok, VP Medical Affairs, rene@nemohealthcare.com